Furthermore, cleaved caspase 3 in WM-3246 cells treated with the three-drug combination but not with sirolimus alone (Fig. 7g), validating the induction of apoptosis by co-inhibition of BCL2 and MCL1 in sirolimus-sensitized NF1/PTEN-deficient human melanoma cells. This evidence concerns the gene BCL2 and melanoma.